Montreal, Canada

Melissa Leblanc

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissa Leblanc. Retrieved from https://idiyas.com/inventor/melissa-leblanc-lfdfrbwo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa Leblanc: Innovator in Therapeutic Compounds

Introduction

Melissa Leblanc is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of therapeutic compounds, particularly in the context of treating diseases mediated by TEAD, such as cancer. Her innovative work has garnered attention in the pharmaceutical industry.

Latest Patents

Melissa holds 1 patent for her invention titled "Therapeutic compounds and methods of use." This patent relates to compounds and methods for using these compounds, as well as pharmaceutical compositions that contain them, aimed at treating various diseases and conditions.

Career Highlights

Melissa is currently employed at Genentech, Inc., where she continues to advance her research and development efforts. Her work is pivotal in the ongoing fight against cancer and other serious health conditions.

Collaborations

Throughout her career, Melissa has collaborated with notable colleagues, including Jason R. Zbieg and Paul Powell Beroza. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Melissa Leblanc is a dedicated inventor whose work in therapeutic compounds is making a difference in the medical field. Her contributions are vital for the development of new treatments for serious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…